| Item 5.07. |
Submission of Matters to a Vote of Security Holders. |
At the 2024 annual meeting of stockholders (the “Annual Meeting”) of Aldeyra Therapeutics, Inc. (the “Company”) held on June 4, 2024, the following proposals were submitted to the stockholders of the Company:
|
|
|
| Proposal 1: |
|
The election of two directors to serve as Class I directors until the Company’s 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. |
|
|
| Proposal 2: |
|
The ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. |
|
|
| Proposal 3: |
|
The approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers. |
For more information about the foregoing proposals, see the Company’s definitive proxy statement on Schedule 14A filed with the United States Securities and Exchange Commission on April 22, 2024 (the “Proxy Statement”). Of the 59,414,489 shares of the Company’s common stock entitled to vote at the Annual Meeting, 44,659,863 shares, or approximately 75.2%, were represented at the meeting in person or by proxy, constituting a quorum. The number of votes cast for, against or withheld, as well as abstentions and broker non-votes, if applicable, in respect of each such proposal is set forth below:
Proposal 1: Election of Directors.
The Company’s stockholders elected the following directors to serve as Class I directors until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal. The votes regarding the election of the directors were as follows:
|
|
|
|
|
|
|
| Director |
|
Votes For |
|
Votes Withheld |
|
Broker Non-Votes |
| Nancy B. Miller-Rich |
|
21,883,289 |
|
12,598,676 |
|
10,177,898 |
| Ben R. Bronstein, M.D. |
|
22,697,358 |
|
11,784,607 |
|
10,177,898 |
Proposal 2: Ratification of Appointment of BDO USA, P.C.
The Company’s stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The votes regarding this proposal were as follows:
|
|
|
|
|
| Votes
For |
|
Votes Against |
|
Votes Abstaining |
| 44,100,430 |
|
372,785 |
|
186,648 |
Proposal 3: Advisory Vote on Executive Compensation.
The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as described in the Proxy Statement. The votes regarding this proposal were as follows:
|
|
|
|
|
|
|
| Votes
For |
|
Votes Against |
|
Votes Abstaining |
|
Broker Non-Votes |
| 31,493,319 |
|
2,862,040 |
|
126,606 |
|
10,177,898 |